These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 10500572)

  • 21. Postmarketing evaluation of mycophenolate mofetil-based triple therapy immunosuppression compared with a conventional azathioprine-based regimen reveals enhanced efficacy and early pharmacoeconomic benefit after renal transplantation.
    Wüthrich RP; Weinreich T; Schwarzkopf AK; Candinas D; Binswanger U
    Transplant Proc; 1998 Dec; 30(8):4096-7. PubMed ID: 9865310
    [No Abstract]   [Full Text] [Related]  

  • 22. Improved primary transplant success rates using a triple regimen of cyclosporine microemulsion, mycophenolate mofetil and prednisone.
    Khauli RB; Medawar WA; Habbal AA; Birbari AE; Daouk MM; Abdelnoor AM; Uwaydah M; Rahman Bizri A; Sanjad S; Ayvazian PJ; Lovewell T; Stoff JS; Yang Fan P; Bigwood P; Harland R
    Transplant Proc; 2001 Aug; 33(5):2776-7. PubMed ID: 11498156
    [No Abstract]   [Full Text] [Related]  

  • 23. Mycophenolate mofetil with lower cyclosporine dose in high-risk renal transplant recipients.
    Esmeraldo RM; Donadi MO; Oliveira ML; Ponte CN; Pinheiro PM
    Transplant Proc; 1999 Nov; 31(7):3007-8. PubMed ID: 10578367
    [No Abstract]   [Full Text] [Related]  

  • 24. Tubular damage and impairment of renal function in transplanted kidneys.
    Donadio C; Puccini R; Lucchesi A; Giordani R; Rizzo G
    Transplant Proc; 1998 Aug; 30(5):2036-7. PubMed ID: 9723381
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinical study of FK 506 in renal transplant recipients.
    Youhua Z; Zhinlian M; Liming W
    Transplant Proc; 2000 Nov; 32(7):1704. PubMed ID: 11119900
    [No Abstract]   [Full Text] [Related]  

  • 26. Simulect, Neoral, Cellcept, and prednisone in kidney recipients with delayed graft function: a prospective controlled study.
    Kumar MS; Kode RK; Pankewycz OG; Laftavi MR; Kumar AM; Damask AM; Vora M; Tomeny MB; Ferry E; Samartino BC; Sierka D; Lingaraju RM; Fyfe B
    Transplant Proc; 2001; 33(7-8):3762-3. PubMed ID: 11750602
    [No Abstract]   [Full Text] [Related]  

  • 27. Steroid withdrawal from tacrolimus-based therapy in renal transplant patients.
    Citterio F; Rigotti P; Scatà MC; Romagnoli J; Baldan N; Marchini F; Castagneto M
    Transplant Proc; 2002 Aug; 34(5):1707-8. PubMed ID: 12176545
    [No Abstract]   [Full Text] [Related]  

  • 28. Safety of the allopurinol-mycophenolate mofetil combination in the treatment of hyperuricemia of kidney transplant recipients.
    Navascués RA; Gómez E; Rodriguez M; Laures AS; Baltar J; Grande JA
    Nephron; 2002 May; 91(1):173-4. PubMed ID: 12021539
    [No Abstract]   [Full Text] [Related]  

  • 29. Mycophenolate mofetil, ATG, and cyclosporine in the induction treatment of renal transplant recipients minimizes the incidence of acute rejection episodes.
    Puig JM; Lloveras J; Fernández-Crespo P; Mir M; Marcas LI; Manresa JM; Masramón J
    Transplant Proc; 1998 Aug; 30(5):2226-7. PubMed ID: 9723449
    [No Abstract]   [Full Text] [Related]  

  • 30. Treatment of chronic rejection in renal transplantation by mycophenolate mofetil (MMF): a preliminary report of six-month experience.
    Jirasiritham S; Sumethkul V; Mavichak V; Jirasiritham S; Chiewsilp P; Leenanupunth C; Kochakarn W
    Transplant Proc; 1998 Nov; 30(7):3576-7. PubMed ID: 9838566
    [No Abstract]   [Full Text] [Related]  

  • 31. Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. U.S. Renal Transplant Mycophenolate Mofetil Study Group.
    Sollinger HW
    Transplantation; 1995 Aug; 60(3):225-32. PubMed ID: 7645033
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mycophenolate mofetil-induced ischemic colitis.
    Kim HC; Park SB
    Transplant Proc; 2000 Nov; 32(7):1896-7. PubMed ID: 11119990
    [No Abstract]   [Full Text] [Related]  

  • 33. Steroid withdrawal in renal transplant recipients.
    Oppenheimer F
    Transplant Proc; 2000 Feb; 32(1A Suppl):14S-15S. PubMed ID: 10686314
    [No Abstract]   [Full Text] [Related]  

  • 34. Chronic renal allograft rejection: no response to mycophenolate mofetil.
    Glicklich D; Gupta B; Schurter-Frey G; Greenstein SM; Schechner RS; Tellis VA
    Transplantation; 1998 Aug; 66(3):398-9. PubMed ID: 9721811
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relation of mycophenolic acid trough levels and adverse events in kidney allograft recipients.
    Smak Gregoor PJ; Hesse CJ; van Gelder T; van der Mast BJ; IJzermans JN; van Besouw NM; Weimar W
    Transplant Proc; 1998 Jun; 30(4):1192-3. PubMed ID: 9636482
    [No Abstract]   [Full Text] [Related]  

  • 36. A randomized trial with steroids and antithymocyte globulins comparing cyclosporine/azathioprine versus tacrolimus/mycophenolate mofetil (CATM2) in renal transplantation.
    Vacher-Coponat H; Moal V; Indreies M; Purgus R; Loundou A; Burtey S; Brunet P; Moussi-Frances J; Daniel L; Dussol B; Berland Y
    Transplantation; 2012 Feb; 93(4):437-43. PubMed ID: 22228415
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mycophenolate mofetil tolerability and dose changes in tacrolimus-treated renal allograft recipients.
    Pascual J; Ocaña J; Marcén R; Fernández A; Galeano C; Alarcón MC; Burgos FJ; Villafruela JJ; Ortuño J
    Transplant Proc; 2006 Oct; 38(8):2398-9. PubMed ID: 17097946
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mycophenolate mofetil in pediatric renal transplantation without induction therapy: results after 12 months of treatment. German Pediatric Renal Transplantation Study Group.
    Staskewitz A; Kirste G; Tönshoff B; Weber LT; Böswald M; Burghard R; Helmchen U; Brandis M; Zimmerhackl LB
    Transplantation; 2001 Mar; 71(5):638-44. PubMed ID: 11292293
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mycophenolate mofetil in pediatric renal transplantation.
    Ettenger R; Sarwal MM
    Transplantation; 2005 Oct; 80(2 Suppl):S201-10. PubMed ID: 16251853
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic allograft nephropathy: effect of cyclosporine reduction and addition of mycophenolate mofetil on progression of renal disease.
    Weir MR; Fink JC; Hanes DS; Gardner J; Klassen DK; Cangro C; Schweitzer E; Bartlett ST
    Transplant Proc; 1999; 31(1-2):1286-7. PubMed ID: 10083574
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.